SCHEMBL22717423

SCHEMBL22717423

COC(=O)c1cc(F)ncc1-c1ccccc1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A3 Q01959 2/20 0.47
▸ SLC6A4 P31645 1/20 0.47
▸ ADORA3 P0DMS8 4/20 0.45
▸ VDR P11473 1/20 0.45
▸ MAPT P10636 4/20 0.44
▸ HSP90AA1 P07900 2/20 0.44
▸ HTT P42858 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ POLQ O75417 2/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ ADORA1 P30542 2/20 0.43
▸ CCNT1 O60563 1/20 0.43
▸ CDK9 P50750 1/20 0.43
▸ KDM4E B2RXH2 3/20 0.42
▸ ALDH1A1 P00352 4/20 0.42
▸ HPGD P15428 3/20 0.42
▸ HSD17B10 Q99714 3/20 0.42
▸ GAA P10253 2/20 0.42
▸ CYP1A2 P05177 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29574586 1.00 SLC6A3 (0.47) SLC6A3SLC6A4ADORA3VDRMAPT
SCHEMBL29574466 0.88 DHODH (0.46) ADORA3HTTPOLQKDM4EALDH1A1
SCHEMBL22717518 0.88 DHODH (0.46) ADORA3HTTPOLQKDM4EALDH1A1
SCHEMBL22732240 0.86 CCNT1 (0.47) ADORA3HTTPOLQCCNT1CDK9
SCHEMBL22717397 0.85 POLQ (0.53) SLC6A3VDRMAPTHSP90AA1HTT
SCHEMBL22717267 0.84 ALDH1A1 (0.50) SLC6A3SLC6A4VDRMAPTHSP90AA1
SCHEMBL25307008 0.83 SDHB (0.46) SLC6A3SLC6A4ADORA3VDRMAPT
SCHEMBL22717860 0.83 KDM4E (0.54) SLC6A3VDRMAPTHSP90AA1HTT
SCHEMBL22717582 0.82 VDR (0.46) SLC6A3SLC6A4VDRMAPTHSP90AA1
SCHEMBL29575360 0.82 VDR (0.46) SLC6A3SLC6A4VDRMAPTHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260049074-A1 THIADIAZOLYL DERIVATIVES IDEAYA BIOSCIENCES, INC. (US) 2026-02-19 — — US disclosed
US-12509454-B2 Thiadiazolyl derivatives IDEAYA BIOSCIENCES, INC. (US) 2025-12-30 — — US disclosed
EP-3976608-B1 THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS IDEAYA BIOSCIENCES INC (US) 2023-11-08 — — EP disclosed
EP-3976608-B1 THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS IDEAYA BIOSCIENCES INC (US) 2023-11-08 — — EP disclosed
US-20230078112-A1 THIADIAZOLYL DERIVATIVES IDEAYA BIOSCIENCES, INC. 2023-03-16 — — US disclosed
EP-3976608-A1 THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS Ideaya Biosciences, Inc. (US) 2022-04-06 — — EP disclosed
CN-114127062-A Thiadiazolyl derivatives as inhibitors of DNA polymerase Theta 伊迪亚生物科学有限公司 2022-03-01 — — CN disclosed
WO-2020243459-A1 THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS IDEAYA BIOSCIENCES, INC. (US) 2020-12-03 — — WO disclosed
WO-2020243459-A1 THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS IDEAYA BIOSCIENCES, INC. (US) 2020-12-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260049074-A1 THIADIAZOLYL DERIVATIVES POLH, POLM, POLD1 SLC6A3 4323/4885SLC6A4 4545/4885ADORA3 1981/4885
US-20230078112-A1 THIADIAZOLYL DERIVATIVES POLQ, POLK, POLA1 SLC6A3 4665/4885SLC6A4 4731/4885ADORA3 3758/4885
US-12509454-B2 Thiadiazolyl derivatives POLD1, POLQ, DNA2 SLC6A3 2893/4885SLC6A4 2496/4885ADORA3 1308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback